If for any reason a trial is terminated early or temporarily suspended the chief investigator should inform the appropriate regulatory authorities and the sponsor. They need to be made aware of why the study was terminated and if any participants are still receiving treatment your plan for their management. All investigators need to be informed immediately and clear reasons given for termination or suspension.
Illustrative example - Magpie trial (audio) |
|
| |
Anticonvulsants are used for pre-eclampsia in the belief they
prevent eclamptic convulsions, and so improve outcome. The Magpie
trial (the full
text is available from the Lancet website) recruited women in 33
countries to either magnesium sulphate (n=5071) or placebo (n=5070).
Primary outcomes were eclampsia and, for women randomised before
delivery, death of the baby. Follow up was until discharge from
hospital after delivery. The trial was stopped early because of
benefit. Lelia Duley, University of Leeds, UK, and the
principal scientist for the trial, talks about what happened when this
happened. Can't see
video controller? Play
it in your media player. |
|
|
What are the immediate consequences of early trial closure and how should those working on the trial be told about the closure ? (MP4, 2 minutes 41 seconds) Can't see the audio controller? Play it in your media player. |
What are the key things to think about with regard to early closure of a trial? (MP4, 41 seconds). Can't see the audio controller? Play it in your media player. |
Checklist of what to include in a letter to investigators on trial closure. This has been contributed by Barbara Farrell who prepared it for the third version of the Trial Management Guide.